Forthcoming Regulatory Changes in the Cannabis/NHP Interface
Bibliographic record
Abstract
On November 22, 2017, Health Canada proposed their new approach to the regulation of cannabis in Canada. If the proposed framework passes into regulation unchanged, the production and processing of cannabis (as an ingredient) will fall under the Cannabis Act, while the manufacturing of cannabis-containing natural health products (NHPs), pharmaceuticals, medical devices, and veterinary health products will fall under the Food and Drugs Act. This overlap between the two regulatory bodies presents an incredible opportunity for Canadian licensed producers (LPs) to integrate finished health products into their businesses, an initiative necessitating careful consideration of the site licensing, formula, marketing, manufacturing, and product licensing requirements of the NHP framework. For the NHP industry, the introduction of cannabis (and its derivatives) as a new permitted ingredient provides development opportunities for products in various dosage forms (topicals, patches, capsules, tinctures etc.) to alleviate non-serious conditions such as social anxiety, sleep disturbances, and appetite-loss, among others. The proposed framework indicates NHP manufacturers will require both the existing NHP manufacturing site license as well as a processor license under the cannabis framework to legally process, package and label products with cannabis. This presentation will provide an update on the proposed Cannabis Act's intersection with the existing regulatory frameworks for NHPs, pharmaceuticals, medical devices and veterinary health products, highlighting opportunities for businesses on both sides to enter the new industry of cannabis health products in Canada. Moreover, future opportunities for LPs and food industry to integrate cannabis and edibles will also be discussed.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.024 | 0.034 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.011 | 0.009 |
| Scholarly communication | 0.017 | 0.006 |
| Open science | 0.007 | 0.005 |
| Research integrity | 0.019 | 0.017 |
| Insufficient payload (model declined to judge) | 0.030 | 0.008 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".